Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tackling antibiotic resistance
Nigel Gibbens outlined a series of significant statistics.
AMR is a global problem that can no longer be ignored

Since the introduction of global costs into the debate on antimicrobial resistance (AMR), there now appears to be more concerted action from governments worldwide. This was one of several significant points made at a session on the subject at the BVA Congress at the Excel Arena in London.

In an authoritative and succinct presentation, Nigel Gibbens, the UK's chief veterinary officer, outlined a series of significant statistics. He told delegates that by the year 2050 it is expected that there will be 10 million human deaths as a consequence of AMR, which will represent a reduction in global GDP of at least 100 trillion US dollars.

He said that at present, 70 per cent of antibiotics are consumed by animals and 30 per cent by humans. He also explained how antibiotics had now been categorised such that 31 are deemed to be critically important (CIA) and 10 not medically important – and that there is increasing pressure on the veterinary profession to reduce its usage of the former.

The speaker pointed out that an AMR global action plan had been established at UN Assembly level and that it had made the following broad recommendations:
  • to reduce antibiotic use in livestock
  • to encourage greater stewardship of antibiotic usage
  • to increase the level of surveillance.
Two years ago, the UK Government set up an enquiry, chaired by Lord O'Neill, that has resulted in the publication of a report, which has recommended tackling the problems of AMR through three different approaches – the setting of an overall antibiotic usage reduction target; the establishment of sector-specific targets; and a very close look at the necessity of using critically important antibiotics in veterinary medicine.

Dr Gibbens indicated that all was not "doom and gloom" and he made reference to the VMD's latest VARSS Report. This indicated that, between 2012 and 2015, there had been a 10 per cent reduction in total sales of antibiotics used in food-producing animals – with fluoroquinolones down by  three per cent and cephalosporins down by 11 per cent. There have been dramatic reductions in the poultry and pig sectors.

The speaker told delegates that the future lies in each veterinary sector taking a critical look at the antibiotics that are being used, why they are being used, and what opportunities there are for further reduction in usage, especially by looking at alternative approaches and attitudes to the promotion of animal health.

In conclusion, Dr Gibbens cautioned vets about being complacent about the application of antibiotics in the treatment of companion animals, especially the CIAs which represent about 80 per cent of those prescribed in cats. He stressed that this was a very important consideration because it is known that E.coli pass between household pets and their human owners.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.